← Back to Clinical Trials
Recruiting NCT06644976

Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later

Trial Parameters

Condition Osteoperosis
Sponsor Meir Hospital, Kfar Saba, Israel
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-08-20
Completion 2025-12
Interventions
femoral neck CRIF

Brief Summary

until today we waited at least 24 hours before surgery of femoral neck fractures in patients who take anticouagolation . in our new reasearch we belive that patients who take NOAC can go under surgery earlier with minimal risk

Eligibility Criteria

Inclusion Criteria: above 18 y.o femoral neck fracture NOAC capable of making inform consent primary surgery \- Exclusion Criteria: * under 18 y.o * anti platelet therapy (aspirin is not included) * creatinine clearance under 50 * active anti cancer therapy * ITP patients * non capable of making inform consent * patients which decide not to proceed with the expeirment

Related Trials